---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-26-000034"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2026-04-07T23:59:59+00:00"
generated_at: "2026-05-15T06:58:13.417047+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ANI Pharmaceuticals dismisses EisnerAmper, appoints Ernst & Young as auditor

## Summary
- EisnerAmper dismissed as independent auditor effective April 1, 2026; Audit Committee approved.
- EisnerAmper reports for FY 2025 and 2024 had no adverse opinion or qualification.
- No disagreements or reportable events during fiscal years 2025, 2024, and through dismissal.
- Ernst & Young (EY) appointed as new independent auditor for fiscal year 2026, effective April 1, 2026.
- No prior consultations with EY regarding accounting matters under Regulation S-K Item 304.

## SEC filing metadata
- accession: 0001023024-26-000034
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2026-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/0001023024-26-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/ani-20260401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-26-000034
- JSON: https://secwatch.observer/filing/0001023024-26-000034.json
- Plain text: https://secwatch.observer/filing/0001023024-26-000034.txt

## Source-grounded claims
- claim_id: 4d11a968517ae9d60ad7dd677100041a1ffe30cf
  claim: ANI PHARMACEUTICALS INC dismissed EisnerAmper LLP as its auditor.
  evidence_excerpt: On April 1, 2026, ANI Pharmaceuticals, Inc. (the “Company”) notified EisnerAmper LLP (“EisnerAmper”) that EisnerAmper would be dismissed as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/0001023024-26-000034-index.htm
- claim_id: e21b71d66ea654a28d8df4fd4231a45c1bfd7d1f
  claim: ANI PHARMACEUTICALS INC engaged Ernst & Young LLP as its auditor.
  evidence_excerpt: On April 1, 2026, the Audit Committee approved the appointment of Ernst & Young LLP (“EY”), effective April 1, 2026, as the Company’s new independent registered public accounting firm for the fiscal year ended December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1023024/000102302426000034/0001023024-26-000034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.